NORGINE is a leading European specialist pharmaceutical company that was founded in 1906. Today, the company has a presence in all major European markets, Australia and New Zealand, with its headquarters in the Netherlands. In the 1990s, the Austrian and Swiss subsidiaries were founded which work together with Liechtenstein as the NORGINE ALPS region.  

With more than 115 years of experience, the NORGINE team manages all aspects of product development, production, marketing, sales and supply. Our areas of specialty are gastroenterology, hepatology, gynecology, and supportive care.

At NORGINE, we are dedicated to developing innovative products that improve 22 million patient lives annually. This is at the heart of our responsibility to patients, healthcare systems and society.